NDC 63323-194-05
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-194
- Requested NDC
- 63323-194-05
- Package NDCs from labels
- 63323-194-05
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-194-05 | ML - Milliliter | 63323-194 | c3bc4d48-618b-4381-b5be-ce6e47d5f72c | 1 | 2012-07-24 |
| 63323-194-10 | ML - Milliliter | 63323-194 | 2ddf230f-6a0d-49ba-aae9-02378ddc8261 | 1 | 2012-07-24 |
| 63323-194-20 | ML - Milliliter | 63323-194 | 47c3b2a6-a499-4223-acc8-7c926c4d8140 | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nafcillin | NAFCILLIN SODIUM | Fresenius Kabi USA, LLC | c39721a3-7b22-4720-9dbd-bc82f03d2af7 | 2026-10-20 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Nafcillin | NAFCILLIN SODIUM | Fresenius Kabi USA, LLC | 3c2581a1-8051-4d7a-a1f7-521248648dc9 | 2026-10-20 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | c7026b15-1228-4acb-beed-4474fcdbb972 | 2026-10-20 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Diazepam | DIAZEPAM | Fresenius Kabi USA, LLC | ae52866a-0b9a-4baf-af1b-f9d5e00c0e56 | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Otulfi | USTEKINUMAB-AAUZ | Fresenius Kabi USA, LLC | 853130e5-7406-4fd6-8138-ff2179195927 | 2026-10-14 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| GLYCOPHOS | SODIUM GLYCEROPHOSPHATE | Fresenius Kabi USA, LLC | e887e473-f1a7-40f1-bd6e-c99e7db7420d | 2026-10-08 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 8223c44a-73a9-4da5-a468-d1d8bdb0bbd6 | 2026-10-07 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | c8e3cc43-238d-4a23-95dc-157c85f83184 | 2026-10-05 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| USTEKINUMAB-AAUZ | USTEKINUMAB-AAUZ | Fresenius Kabi USA, LLC | a6d75316-c9a7-49cf-83be-b7b6c6cecf7a | 2026-09-30 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Haloperidol | HALOPERIDOL LACTATE | Fresenius Kabi USA, LLC | b1ad2abd-a9d6-44e3-957b-36a73260f4f5 | 2026-09-22 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Cytarabine | CYTARABINE | Fresenius Kabi USA, LLC | c4fdc56e-efd7-4825-a518-ef430b2b3df0 | 2026-09-21 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Fresenius Kabi USA, LLC | a694bbc3-4eb0-4c1e-b4ff-b8abc3e5148e | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Nicardipine Hydrochloride | NICARDIPINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 6fd1dafe-4b51-49c7-bce1-c4295b2bd292 | 2026-09-07 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | a798faf5-cd97-4e35-a700-94c372978c46 | 2026-09-02 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| TYENNE | TOCILIZUMAB-AAZG | Fresenius Kabi USA, LLC | ad76441d-da59-47df-8d9d-2243005180f0 | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 2e5fe9f4-78e5-4af4-8bf9-9680e5dc5e88 | 2026-08-20 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | df18a603-ca12-4b26-83b5-9dd07b6453ab | 2026-08-18 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| sugammadex | SUGAMMADEX | Fresenius Kabi USA, LLC | 8e685b67-6804-4d97-b43e-0259b3fe231f | 2026-08-03 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Rocuronium | ROCURONIUM BROMIDE | Fresenius Kabi USA, LLC | 04c9812d-5aa3-4949-ad02-c618028f1bb0 | 2026-08-02 | Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
| Morphine Sulfate | MORPHINE SULFATE | Fresenius Kabi USA, LLC | 582f42e5-444e-4246-af8c-e7e28097c69a | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | Fresenius Kabi USA, LLC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.